---
document_datetime: 2025-11-23 07:01:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/ciambra.html
document_name: ciambra.html
version: success
processing_time: 0.1102525
conversion_datetime: 2025-12-23 20:31:36.127997
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Ciambra

[RSS](/en/individual-human-medicine.xml/65845)

##### Withdrawn

This medicine's authorisation has been withdrawn

pemetrexed

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Ciambra](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 12 October.2023, the European Commission withdrew the marketing authorisation for Ciambra (pemetrexed) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Menarini International Operations Luxembourg S.A., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Ciambra was granted marketing authorisation in the EU on 2 December 2015 for the treatment of malignant pleural mesothelioma and non-small cell lung cancer. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2019. The product had not been marketed in the EU since 2021.

Ciambra is a generic medicine of Alimta. There are other generic medicinal products of Alimta authorised and marketed in the EU. The European Public Assessment Report (EPAR) for Ciambra is updated to indicate that the marketing authorisation is no longer valid.

Ciambra : EPAR - Summary for the public

Reference Number: EMA/802043/2015

English (EN) (157.26 KB - PDF)

**First published:** 03/05/2016

**Last updated:** 17/10/2024

[View](/en/documents/overview/ciambra-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-12)

български (BG) (214.58 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/bg/documents/overview/ciambra-epar-summary-public_bg.pdf)

español (ES) (155.53 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/es/documents/overview/ciambra-epar-summary-public_es.pdf)

čeština (CS) (198.3 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/cs/documents/overview/ciambra-epar-summary-public_cs.pdf)

dansk (DA) (151.46 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/da/documents/overview/ciambra-epar-summary-public_da.pdf)

Deutsch (DE) (157.69 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/de/documents/overview/ciambra-epar-summary-public_de.pdf)

eesti keel (ET) (148.63 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/et/documents/overview/ciambra-epar-summary-public_et.pdf)

ελληνικά (EL) (216.9 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/el/documents/overview/ciambra-epar-summary-public_el.pdf)

français (FR) (157.37 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/fr/documents/overview/ciambra-epar-summary-public_fr.pdf)

hrvatski (HR) (180.54 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/hr/documents/overview/ciambra-epar-summary-public_hr.pdf)

italiano (IT) (153.52 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/it/documents/overview/ciambra-epar-summary-public_it.pdf)

latviešu valoda (LV) (191.45 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/lv/documents/overview/ciambra-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (187.03 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/lt/documents/overview/ciambra-epar-summary-public_lt.pdf)

magyar (HU) (180.18 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/hu/documents/overview/ciambra-epar-summary-public_hu.pdf)

Malti (MT) (198.79 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/mt/documents/overview/ciambra-epar-summary-public_mt.pdf)

Nederlands (NL) (155.41 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/nl/documents/overview/ciambra-epar-summary-public_nl.pdf)

polski (PL) (197.19 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/pl/documents/overview/ciambra-epar-summary-public_pl.pdf)

português (PT) (155.53 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/pt/documents/overview/ciambra-epar-summary-public_pt.pdf)

română (RO) (190.64 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/ro/documents/overview/ciambra-epar-summary-public_ro.pdf)

slovenčina (SK) (187.69 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sk/documents/overview/ciambra-epar-summary-public_sk.pdf)

slovenščina (SL) (180.74 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sl/documents/overview/ciambra-epar-summary-public_sl.pdf)

Suomi (FI) (150.57 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/fi/documents/overview/ciambra-epar-summary-public_fi.pdf)

svenska (SV) (150.29 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sv/documents/overview/ciambra-epar-summary-public_sv.pdf)

Ciambra : EPAR - Risk-management-plan summary

English (EN) (143.13 KB - PDF)

**First published:** 03/05/2016

**Last updated:** 17/10/2024

[View](/en/documents/rmp-summary/ciambra-epar-risk-management-plan-summary_en.pdf)

## Product information

Ciambra : EPAR - Product Information

English (EN) (2.7 MB - PDF)

**First published:** 03/05/2016

**Last updated:** 17/10/2024

[View](/en/documents/product-information/ciambra-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-472)

български (BG) (3.23 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/bg/documents/product-information/ciambra-epar-product-information_bg.pdf)

español (ES) (3.35 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/es/documents/product-information/ciambra-epar-product-information_es.pdf)

čeština (CS) (4.31 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/cs/documents/product-information/ciambra-epar-product-information_cs.pdf)

dansk (DA) (1.53 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/da/documents/product-information/ciambra-epar-product-information_da.pdf)

Deutsch (DE) (2.87 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/de/documents/product-information/ciambra-epar-product-information_de.pdf)

eesti keel (ET) (2.3 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/et/documents/product-information/ciambra-epar-product-information_et.pdf)

ελληνικά (EL) (3.73 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/el/documents/product-information/ciambra-epar-product-information_el.pdf)

français (FR) (3.33 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/fr/documents/product-information/ciambra-epar-product-information_fr.pdf)

hrvatski (HR) (2.68 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/hr/documents/product-information/ciambra-epar-product-information_hr.pdf)

íslenska (IS) (1.47 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/is/documents/product-information/ciambra-epar-product-information_is.pdf)

italiano (IT) (2.58 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/it/documents/product-information/ciambra-epar-product-information_it.pdf)

latviešu valoda (LV) (2.15 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/lv/documents/product-information/ciambra-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.89 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/lt/documents/product-information/ciambra-epar-product-information_lt.pdf)

magyar (HU) (2.56 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/hu/documents/product-information/ciambra-epar-product-information_hu.pdf)

Malti (MT) (3.38 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/mt/documents/product-information/ciambra-epar-product-information_mt.pdf)

Nederlands (NL) (3.46 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/nl/documents/product-information/ciambra-epar-product-information_nl.pdf)

norsk (NO) (1.2 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/no/documents/product-information/ciambra-epar-product-information_no.pdf)

polski (PL) (3.23 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/pl/documents/product-information/ciambra-epar-product-information_pl.pdf)

português (PT) (1.71 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/pt/documents/product-information/ciambra-epar-product-information_pt.pdf)

română (RO) (3.43 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/ro/documents/product-information/ciambra-epar-product-information_ro.pdf)

slovenčina (SK) (2.45 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sk/documents/product-information/ciambra-epar-product-information_sk.pdf)

slovenščina (SL) (2.97 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sl/documents/product-information/ciambra-epar-product-information_sl.pdf)

Suomi (FI) (1.33 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/fi/documents/product-information/ciambra-epar-product-information_fi.pdf)

svenska (SV) (1.28 MB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sv/documents/product-information/ciambra-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0008 17/08/2022

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Ciambra : EPAR - All Authorised presentations

English (EN) (43.43 KB - PDF)

**First published:** 03/05/2016

**Last updated:** 17/10/2024

[View](/en/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-4)

български (BG) (121.2 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/bg/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_bg.pdf)

español (ES) (33.17 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/es/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_es.pdf)

čeština (CS) (76.05 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/cs/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (35.22 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/da/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (47.16 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/de/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (56.57 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/et/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (91.65 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/el/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_el.pdf)

français (FR) (64.55 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/fr/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (62.97 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/hr/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (54.07 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/is/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_is.pdf)

italiano (IT) (56.04 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/it/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (70.12 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/lv/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (64.55 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/lt/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (62.85 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/hu/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (66.4 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/mt/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (106.58 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/nl/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (53.49 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/no/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_no.pdf)

polski (PL) (79.04 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/pl/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_pl.pdf)

português (PT) (49.71 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/pt/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_pt.pdf)

română (RO) (92.4 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/ro/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (90.45 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sk/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (48.96 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sl/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (33.7 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/fi/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (54.43 KB - PDF)

**First published:**

03/05/2016

**Last updated:**

17/10/2024

[View](/sv/documents/all-authorised-presentations/ciambra-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Ciambra Active substance pemetrexed disodium hemipentahydrate International non-proprietary name (INN) or common name pemetrexed Therapeutic area (MeSH)

- Carcinoma, Non-Small-Cell Lung
- Mesothelioma

Anatomical therapeutic chemical (ATC) code L01BA04

### Pharmacotherapeutic group

Antineoplastic agents

### Therapeutic indication

**Malignant pleural mesothelioma**

Ciambra in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.

**Non-small cell lung cancer**

Ciambra in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Ciambra is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

Ciambra is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

## Authorisation details

EMA product number EMEA/H/C/003788

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Menarini International Operations Luxembourg S.A.

1 Avenue de la Gare

Opinion adopted 24/09/2015 Marketing authorisation issued 02/12/2015 Withdrawal of marketing authorisation 12/10/2023 Revision 7

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Ciambra : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (259.88 KB - PDF)

**First published:** 20/03/2017

**Last updated:** 17/10/2024

[View](/en/documents/procedural-steps-after/ciambra-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Ciambra : EPAR - Public assessment report

Adopted

Reference Number: EMA/802052/2015

English (EN) (717.59 KB - PDF)

**First published:** 03/05/2016

**Last updated:** 17/10/2024

[View](/en/documents/assessment-report/ciambra-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Ciambra

Adopted

Reference Number: EMA/CHMP/572488/2015

English (EN) (114.09 KB - PDF)

**First published:** 25/09/2015

**Last updated:** 17/10/2024

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-ciambra_en.pdf)

#### News on Ciambra

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 September 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-21-24-september-2015) 25/09/2015

**This page was last updated on** 17/10/2024

## Share this page

[Back to top](#main-content)